ANTI-BACTERIAL VACCINE COMPOSITIONS

The present invention relates generally to the identification of genes responsible for virulence of streptococci, thereby allowing for production of novel attenuated mutant strains useful in vaccines, and identification of new anti-bacterial agents that target the virulence genes and their products....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BOWERSOCK, TERRY, LYNN, LOWERY, DAVID, EARL, MARTIN, STEPHEN, KLEIN, LORETTA, KAY, WILSON, THOMAS, LARRY, FULLER, TROY, EUGENE, GODBEE, TROY, EUGENE
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates generally to the identification of genes responsible for virulence of streptococci, thereby allowing for production of novel attenuated mutant strains useful in vaccines, and identification of new anti-bacterial agents that target the virulence genes and their products. La présente invention concerne de manière générale l'identification des gènes responsables de la virulence des streptocoques, permettant ainsi la production de nouvelles souches mutantes atténuées utilisées dans les vaccins, et l'identification de nouveaux agents antibactériens ciblant les gènes virulents et leurs produits.